Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) Net Margin (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Net Margin for 2 consecutive years, with 640.82% as the latest value for Q2 2025.

  • On a quarterly basis, Net Margin changed N/A to 640.82% in Q2 2025 year-over-year; TTM through Sep 2025 was 3572.3%, a N/A change, with the full-year FY2024 number at 478.95%, changed N/A from a year prior.
  • Net Margin was 640.82% for Q2 2025 at Pyxis Oncology, down from 33.09% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 33.09% in Q1 2024 to a low of 640.82% in Q2 2025.